PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Medicare
The Potential Pain in Deficit Reduction
The US National Commission on Fiscal Responsibility’s draft report report signals US embrace of a fixed annual global budget for health care spending — experience in other countries suggests this will add to pressure for further cost controls on medicines beyond what is ordered up in Obamacare.
Last week, Erskine Bowles and Alan Simpson, co-chairs for [...]
Posted in Regulatory, healthcare Also tagged deficit, fiscal reform, Medicaid, Obamacare, Pharma 2 Comments
FDA and CMS: A Partnership On Approval
FDA announced last week that the lengthy delay that punctuates the initial approval of a medical product and it reaching the hands of consumers is to be addressed in a planned project in which the Agency will make joint approval decisions with the Medicare division of the Centers for Medicare and Medicaid Services (CMS). The [...]
Government Crackdown on the C-Suite
Over the past decade, the drug industry has paid tens of billions of dollars to settle state and federal lawsuits involving the False Claims Act—defrauding Medicare and Medicaid, promoting drugs for unapproved uses, paying kickbacks to doctors and pharmacies, and the like. Stories about off-label promotion of drugs with serious adverse effects and no proven [...]
Posted in Legal Also tagged C-Suite, False Claims Act, healthcare fraud, Medicaid, OIG Leave a comment
Pharma Cheers Health Reform Legislation
Image by SEIU International via Flickr
After months of increasingly rancorous debate, the House finally approved legislation March 21 that makes significant changes in the nation’s health care system. The Senate is slated to approve the House-passed changes to its original reform bill shortly.
Of most importance to pharmaceutical companies, the legislation promises to significantly expand the [...]
Posted in News Also tagged Health care, health insurance, Insurance, Medicaid, Medicare Part D coverage gap, Prescription drug, United States 3 Comments
How Will Accountable Care Organizations Hit Drug Sales?